home
portfolio
approach
team
careers
news
contact
investor portal

home
portfolio
approach
team
careers
news
contact
investor portal

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Post navigation

Previous PostPrevious Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

Next PostNext Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Search for:

Recent Comments

Archives

Categories

No categories

Meta

Log in
Entries feed
Comments feed
WordPress.org

© Nextech Invest Ltd. | privacy policy